MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cashman, J. R.
Right arrow Articles by Ziegler, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cashman, J. R.
Right arrow Articles by Ziegler, D. M.

Contribution of N-oxygenation to the metabolism of MPTP (1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine) by various liver preparations

JR Cashman and DM Ziegler

Liver microsomes from uninduced mice and rats catalyze NADPH- and oxygen-dependent N-oxygenation of the neurotoxin MPTP (1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine). The N-oxide is the principal product and accounts for 95-96% of the total MPTP metabolized by microsomes. Demethylation of MPTP is detectable but the rate of nor- MPTP formation was never more than 4-6% of the rate of N-oxygenation. Studies on the biochemical mechanisms for N-oxygenation of MPTP suggest that this reaction is catalyzed exclusively by the flavin-containing monooxygenase. This conclusion is based on the effects of selective cytochrome P-450 inhibitors, positive effectors, and alternate substrates for the flavin-containing monooxygenase as well as on studies with the purified hog liver enzyme. MPTP is an excellent substrate for this monooxygenase with a Km of 30-33 microM. Limited studies with human liver whole homogenates suggest that N-oxygenation is also a major route for the metabolism of MPTP in man and the rate of N-oxide formation is approximately equal to the rate of mitochondrial monoamine oxidase-dependent MPDP+ (1-methyl-4-phenyl-2,3- dihydropyridinium species) production.

Volume 29, Issue 2, pp. 163-167, 02/01/1986
Copyright © 1986 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
J. R. Cashman and J. Zhang
Interindividual Differences of Human Flavin-Containing Monooxygenase 3: Genetic Polymorphisms and Functional Variation
Drug Metab. Dispos., October 1, 2002; 30(10): 1043 - 1052.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
R. J. Rodriguez and C. L. Miranda
Isoform Specificity of N-Deacetyl Ketoconazole by Human and Rabbit Flavin-Containing Monooxygenases
Drug Metab. Dispos., September 1, 2000; 28(9): 1083 - 1086.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
S.'i. Yoshihara, K. Harada, and S. Ohta
Metabolism of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Perfused Rat Liver: Involvement of Hepatic Aldehyde Oxidase as a Detoxification Enzyme
Drug Metab. Dispos., May 1, 2000; 28(5): 538 - 543.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
R. J. Rodriguez, P. J. Proteau, B. L. Marquez, C. L. Hetherington, C. J. Buckholz, and K. L. O'Connell
Flavin-Containing Monooxygenase-Mediated Metabolism of N-Deacetyl Ketoconazole by Rat Hepatic Microsomes
Drug Metab. Dispos., August 1, 1999; 27(8): 880 - 886.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
R. J. Rodriguez and D. Acosta Jr.
Metabolism of Ketoconazole and Deacetylated Ketoconazole by Rat Hepatic Microsomes and Flavin-Containing Monooxygenases
Drug Metab. Dispos., June 1, 1997; 25(6): 772 - 777.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1986 by the American Society for Pharmacology and Experimental Therapeutics